By Andrew Silver and Patrick Wingrove SHANGHAI/LONDON, Nov 12 (Reuters) – Eli Lilly on Thursday became the first drugmaker to win approval in China for a GLP-1 weight-loss pill, giving it an early
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)